Today's guest on Seeking Alpha's Cannabis Investing Podcast will be familiar to many investors both within - and outside of - the cannabis space. Tim Seymour, of CNBC Fast Money fame, is the Founder and Chief Investment Officer of Seymour Asset Management. Tim has over 20 years of general investment experience and was an early stage investor and recognized voice in the cannabis industry. He serves as a board member or in an advisory role for several private cannabis companies.
More recently, he launched an actively managed pure play Cannabis ETF, the Amplify Seymour Cannabis ETF (CNBS), where he serves as Portfolio Manager. Still fresh on the heels of CNBS' July 23 launch, Tim weighs in on a broad array of macro trends affecting cannabis investors, while also providing a detailed and intimate perspective on a dozen companies in the space.
Topics include:
2:00 - Tim's backstory: What drew him to cannabis investing? 13:00 - Launching the Amplify Seymour Cannabis ETF (CNBS), and Tim's Fast Money platform 20:00 - After so much carnage in the space, are Cannabis sector valuations finally more reasonable? 27:30 - What did prognosticators like Deloitte get wrong in the lead-up to legalization in Canada and California? 37:30 - How does Tim get access to US markets via CNBS and when does he see investors being able to profit from markets beyond Canada? 50:45 - How is CNBS structured and how does Tim value stocks in the space? 1:01:00 - Effect of Bruce Linton firing on Canopy Growth Corporation (CGC) 1:09:45 - Which companies are best positioned for global growth? (ACB) 1:15:30 - Stock recommendation: MediPharm Labs (MEDIF) (Canadian ticker: LABS) 1:17:30 - Concluding remarks: Where's the indus